针对治疗脏疾病的铁灭菌
1Division of Nephrology, Rheumatology and Endocrinology, Tohoku University Graduate School of Medicine, Sendai, Japan. eikan@med.tohoku.ac.jp.
Clinical and experimental nephrology
|April 21, 2024
概括
铁亡,一种由铁和脂质氧化驱动的细胞死亡,越来越多地与脏疾病有关. 未来的研究应该专注于向铁死,以有效治疗病.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 铁亡是一种受调节的细胞死亡,其特征是依赖铁的脂质过氧化.
- 关键的调节途径包括谷氨过氧化酶4 (GPX4) 和FSP1-辅酶Q10途径.
- 铁亡与各种脏疾病有关,包括缺血 - 反损伤和毒素诱导的损伤.
研究的目的:
- 审查铁死在病中的作用.
- 讨论针对病态的化向疗法的潜力.
- 要突出涉及细胞死亡的治疗干预措施的考虑因素.
主要方法:
- 关于铁灭症研究的文献综述.
- 在病理生理学的ferroptosis参与的分析.
- 讨论治疗策略和挑战.
主要成果:
- 铁亡是多种损伤模型中的一个重要因素.
- 向ferroptosis为脏疾病提供了一个有前途的治疗途径.
- 仔细考虑细胞类型,死亡模式和疾病阶段对于治疗成功至关重要.
结论:
- 铁死在病的进展中起着至关重要的作用.
- 开发适用于临床的针对铁亡的药物是未来的一个关键方向.
- 需要进一步的研究来阐明铁亡在人类病中的确切作用.
相关概念视频
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88


